- Home
- DOMH vs DXR Comparison
DOMH vs DXR Comparison
Compare DOMH & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DOMH | DXR |
|---|---|---|
| Founded | 1967 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 74.0M | 66.3M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | DOMH | DXR |
|---|---|---|
| Price | $3.97 | $12.71 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $25.00 |
| AVG Volume (30 Days) | ★ 265.7K | 4.3K |
| Earning Date | 11-10-2025 | 01-01-0001 |
| Dividend Yield | ★ 14.10% | N/A |
| EPS Growth | N/A | ★ 3.46 |
| EPS | ★ 9.19 | 0.36 |
| Revenue | ★ $99,588,000.00 | $66,306.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ $0.42 | $35.63 |
| Revenue Growth | ★ 691.07 | N/A |
| 52 Week Low | $0.83 | $6.55 |
| 52 Week High | $13.58 | $14.15 |
Technical Indicators
Market Signals| Indicator | DOMH | DXR |
|---|---|---|
| Relative Strength Index (RSI) | 36.53 | 46.38 |
| Support Level | $3.73 | $12.21 |
| Resistance Level | $5.00 | $13.02 |
| Average True Range (ATR) | 0.29 | 0.49 |
| MACD | -0.03 | -0.05 |
| Stochastic Oscillator | 19.22 | 29.42 |
Price Performance
Historical ComparisonAbout DOMH Dominari Holdings Inc.
Dominari Holdings Inc through its various subsidiaries, is currently engaged in wealth management, investment banking, securities sales and trading and asset management. The company operates in two reportable business segments: Dominari Financial and Legacy AIkido. The Dominari Financial reportable business segment represents the Company's broker-dealer business, which is composed of mostly underwriting and transactional service activities. The Legacy AIkido reportable business segment includes Aikido Labs, which manages the investments holdings of the legacy entity. It generates the majority of its revenue from the Dominari Financial segment.
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.